Registered entities
Abfero Pharmaceuticals, Inc.
Reg. No. 811705490United States
Investor mix
4 investors on record; lead investors include Eureka.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Other / undisclosed | 3 | 75% |
Developer of oral iron chelators for the treatment of iron overload diseases
4 investors on record; lead investors include Eureka.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Other / undisclosed | 3 | 75% |